Top Story

Hard-to-treat patients with sclerosis respond to stem cell transplantation

Hard-to-treat patients with sclerosis respond to stem cell transplantation
October 26, 2018
Meeting News

Hematopoietic stem cell transplantation for scleroderma durable after 6 to 11 years

October 23, 2018
CHICAGO — A long-term follow-up to the Scleroderma: Cyclophosphamide or Transplantation trial demonstrated that the clinical benefits of myeloablative autologous…
In the Journals

Wearable devices linked to increased activity in rheumatic diseases

October 11, 2018
The use of wearable devices that track movement is effective in significantly increasing the amount of and time spent performing moderate to vigorous physical activity…
In the Journals

Patients with SSc-related Raynaud's syndrome identify with patterns linked to microangiopathy

September 19, 2018
Patients with Raynaud’s phenomenon related to systemic sclerosis identify with distinct patterns of the disease that may be linked to progression of systemic…
More Headlines »

Multidisciplinary Perspectives in Giant Cell Arteritis: A Team-based Approach for Improved Quality of Care

This activity is supported by an educational grant from Genentech, Inc.

Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. If left untreated, patients…
More »
Meeting News Coverage

VIDEO: Khanna discusses safety, efficacy of tocilizumab for systemic sclerosis

June 11, 2016
More »

AWIR 2nd Annual Immunology Bootcamp Part 2: T- and B-Cell, IL-12, IL-17, and IL-23 Biology and Inhibitors

This activity is supported by educational grants from AbbVie, Inc.; Amgen; Bristol-Myers Squibb; Pfizer, Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis, vasculitis, and axial…
More »